AlniditanAlternative Names: R-91274
Latest Information Update: 08 Jul 1997
At a glance
- Originator Janssen L.P.
- Class Antimigraines; Benzopyrans
- Mechanism of Action Serotonin 1D receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Migraine